02197nam a2200481 i 4500001001300000003000600013005001700019007001400036008004100050040003500091042000800126043001200134074001600146086002000162110007300182245016800255264007100423300002400494336000800518337001600526338001900542490007700561500002400638500002100662500003600683500002500719504004100744533010700785776017300892776017401065810005801239050002101297610004101318650004401359650004301403650003201446650003201478650005701510650005101567650002801618650003501646655003401681on1062362734OCoLC20181218152241.0he bmb024bbca181109s2018 dcu bb f000 0 eng c aPUCPRbengerdacGPOdGPOdMvI apcc an-us--- a1008-D (MF)0 aY 1.1/8:115-7281 aUnited States.bCongress.bHouse.bCommittee on Energy and Commerce,10aMedicaid Drug Review, Utilization, Good Governance Improvement Act :breport (to accompany H.R. 5799) (including cost estimate of the Congressional Budget Office). 1a[Washington, D.C.] :b[U.S. Government Publishing Office],c[2018] a147 pages ;c24 cm. btxt bh2rdamedia bhe2rdacarrier1 aReport / 115th Congress, 2d session, House of Representatives ;v115-728 aTitle from caption. a"June 12, 2018." aShipping list no.: 2018-0192-M. aCRDP Program record. aIncludes bibliographical references. aMicrofiche.b[Washington, D.C.] :cU.S. Government Printing Office,d[2018]e2 microfiches : negative.08iPrint version:aUnited States. Congress. House. Committee on Energy and Commerce.tMedicaid Drug Review, Utilization, Good Governance Improvement Actw(OCoLC)104170825508iOnline version:aUnited States. Congress. House. Committee on Energy and Commerce.tMedicaid Drug Review, Utilization, Good Governance Improvement Actw(OCoLC)10417068831 aUnited States.bCongress.bHouse.tReport ;v115-728. 4aKF32b.E55 2018j10aUnited States.tSocial Security Act. 0aMedicare beneficiariesxIdentification. 0aDrugszUnited StatesxSafety measures. 0aMedicare fraudxPrevention. 0aMedicaid fraudxPrevention. 0aFraudxPreventionxGovernment policyzUnited States. 0aOpioid abusexTreatmentzUnited StatesxCosts. 0aMedicarexCost control. 0aMedicarexLaw and legislation. 7aLegislative materials.2lcgft